Opinion: Global health should not be determined by pharma investors and shareholders
What could go wrong when pharmaceutical company shareholders and investors shape the public health response to Covid-19?
Everything, of course, including perpetuating the pandemic with immense avoidable suffering and death. And that’s exactly what happened last week at the annual shareholder meetings of Moderna, Pfizer, and Johnson & Johnson.
